Screener
Pacira BioSciences, Inc. PCRX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 16) | ||
| Stockholders’ equity: | ||
| Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.001; 250,000,000 shares authorized; 48,328,201 shares issued and 39,309,610 shares outstanding at March 31, 2026 and 47,890,777 shares issued and 41,116,739 shares outstanding at December 31, 2025 | 48 | 48 |
| Treasury stock, at cost, inclusive of excise tax and broker fees, 9,018,591 and 6,774,038 shares at March 31, 2026 and December 31, 2025, respectively | (227,013) | (176,565) |
| Additional paid-in capital | 1,073,809 | 1,064,623 |
| Accumulated deficit | (196,406) | (199,322) |
| Accumulated other comprehensive income | 3,455 | 4,327 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s common stock, par value (in dollars per share)?
- Pacira BioSciences, Inc. (PCRX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Pacira BioSciences, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Pacira BioSciences, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude